» Articles » PMID: 8890231

Interaction Between Complement Subcomponent C1q and the Klebsiella Pneumoniae Porin OmpK36

Overview
Journal Infect Immun
Date 1996 Nov 1
PMID 8890231
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction between C1q, a subcomponent of the complement classical pathway component C1, and OmpK36, a porin protein from Klebsiella pneumoniae, was studied in a solid-phase direct-binding assay, inhibition assays with the purified globular and collagen-like regions of C1q, and cross-linking experiments. We have shown that the binding of C1q to the OmpK36 porin of the serum-sensitive strain K. pneumoniae KT707 occurs in an in vivo situation and that this binding leads to activation of the complement classical pathway and the subsequent deposition of complement components C3b and C5b-9 on the OmpK36 porin. Scatchard analysis of the binding of [125I]C1q to the OmpK36 porin showed two binding sites with dissociation constants of 1.5 and 75 nM. The decrease of [125I]C1q binding to the OmpK36 porin in buffer with increasing salt concentrations and the pIs of the C1q subcomponent (10.3) and OmpK36 porin (4.5) suggest that charged amino acids are involved in the binding phenomenon. In inhibition assays, only the globular regions of C1q inhibited the interaction between C1q and OmpK36 porin, demonstrating that C1q binds to porin through its globular region and not through the collagen-like stalks.

Citing Articles

Screening of linear B-cell epitopes and its proinflammatory activities of outer membrane protein P2.

Wu J, Nan W, Peng G, Hu H, Xu C, Huang J Front Cell Infect Microbiol. 2023; 13:1192651.

PMID: 37207184 PMC: 10189045. DOI: 10.3389/fcimb.2023.1192651.


The yin and the yang of early classical pathway complement disorders.

Sullivan K Clin Exp Immunol. 2022; 209(2):151-160.

PMID: 35648651 PMC: 9390844. DOI: 10.1093/cei/uxac056.


Secondary Complement Deficiency Impairs Anti-Microbial Immunity to and During Severe Acute COVID-19.

Ali Y, Lynch N, Khatri P, Bamigbola I, Chan A, Yabuki M Front Immunol. 2022; 13:841759.

PMID: 35572551 PMC: 9094484. DOI: 10.3389/fimmu.2022.841759.


Innate Host Defense against Klebsiella pneumoniae and the Outlook for Development of Immunotherapies.

Opoku-Temeng C, Malachowa N, Kobayashi S, DeLeo F J Innate Immun. 2021; 14(3):167-181.

PMID: 34628410 PMC: 9149408. DOI: 10.1159/000518679.


Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.

Rocker A, Lacey J, Belousoff M, Wilksch J, Strugnell R, Davies M mBio. 2020; 11(2).

PMID: 32291303 PMC: 7157821. DOI: 10.1128/mBio.00603-20.


References
1.
Marques G, Anton L, Barrio E, Sanchez A, Ruiz S, Gavilanes F . Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J Biol Chem. 1993; 268(14):10393-402. View

2.
Alberti S, Marques G, Camprubi S, Merino S, Tomas J, Vivanco F . C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun. 1993; 61(3):852-60. PMC: 302811. DOI: 10.1128/iai.61.3.852-860.1993. View

3.
Ghebrehiwet B, Lim B, Peerschke E, Willis A, Reid K . Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med. 1994; 179(6):1809-21. PMC: 2191527. DOI: 10.1084/jem.179.6.1809. View

4.
Alberti S, Schirmer T, Rummel G, Tomas J, Rosenbusch J, Benedi V . A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect Immun. 1995; 63(3):903-10. PMC: 173088. DOI: 10.1128/iai.63.3.903-910.1995. View

5.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View